These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 34558234)

  • 21. Nanoparticle-based local antimicrobial drug delivery.
    Gao W; Chen Y; Zhang Y; Zhang Q; Zhang L
    Adv Drug Deliv Rev; 2018 Mar; 127():46-57. PubMed ID: 28939377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors pivotal for designing of nanoantimicrobials: an exposition.
    Jamil B; Imran M
    Crit Rev Microbiol; 2018 Feb; 44(1):79-94. PubMed ID: 28421881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria.
    Kester JC; Fortune SM
    Crit Rev Biochem Mol Biol; 2014; 49(2):91-101. PubMed ID: 24328927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
    Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
    J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New approaches to the treatment of biofilm-related infections.
    Wilkins M; Hall-Stoodley L; Allan RN; Faust SN
    J Infect; 2014 Nov; 69 Suppl 1():S47-52. PubMed ID: 25240819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat.
    Mahmoudi M; Serpooshan V
    ACS Nano; 2012 Mar; 6(3):2656-64. PubMed ID: 22397679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The challenge of treating biofilm-associated bacterial infections.
    del Pozo JL; Patel R
    Clin Pharmacol Ther; 2007 Aug; 82(2):204-9. PubMed ID: 17538551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
    Weldrick PJ; Hardman MJ; Paunov VN
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biofilm-related disease.
    Del Pozo JL
    Expert Rev Anti Infect Ther; 2018 Jan; 16(1):51-65. PubMed ID: 29235402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic resistance of bacterial biofilms.
    Høiby N; Bjarnsholt T; Givskov M; Molin S; Ciofu O
    Int J Antimicrob Agents; 2010 Apr; 35(4):322-32. PubMed ID: 20149602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging nanotechnologies for targeting antimicrobial resistance.
    Weldick PJ; Wang A; Halbus AF; Paunov VN
    Nanoscale; 2022 Mar; 14(11):4018-4041. PubMed ID: 35234774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial Resistance and Inorganic Nanoparticles.
    Balderrama-González AS; Piñón-Castillo HA; Ramírez-Valdespino CA; Landeros-Martínez LL; Orrantia-Borunda E; Esparza-Ponce HE
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is combined medication with natural medicine a promising therapy for bacterial biofilm infection?
    Zhang L; Liang E; Cheng Y; Mahmood T; Ge F; Zhou K; Bao M; Lv L; Li L; Yi J; Lu C; Tan Y
    Biomed Pharmacother; 2020 Aug; 128():110184. PubMed ID: 32450528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antibiofilm and anti-adhesion effects of magnesium oxide nanoparticles against antibiotic resistant bacteria.
    Hayat S; Muzammil S; Rasool MH; Nisar Z; Hussain SZ; Sabri AN; Jamil S
    Microbiol Immunol; 2018 Apr; 62(4):211-220. PubMed ID: 29405384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies to Promote the Journey of Nanoparticles Against Biofilm-Associated Infections.
    Wang X; Wang D; Lu H; Wang X; Wang X; Su J; Xia G
    Small; 2024 Mar; 20(10):e2305988. PubMed ID: 38178276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combatting antibiotic-resistant bacteria using nanomaterials.
    Gupta A; Mumtaz S; Li CH; Hussain I; Rotello VM
    Chem Soc Rev; 2019 Jan; 48(2):415-427. PubMed ID: 30462112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supramolecular Antibacterial Materials for Combatting Antibiotic Resistance.
    Li X; Bai H; Yang Y; Yoon J; Wang S; Zhang X
    Adv Mater; 2019 Feb; 31(5):e1805092. PubMed ID: 30536445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surviving as a Community: Antibiotic Tolerance and Persistence in Bacterial Biofilms.
    Yan J; Bassler BL
    Cell Host Microbe; 2019 Jul; 26(1):15-21. PubMed ID: 31295420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms and Control Strategies of Antibiotic Resistance in Pathological Biofilms.
    Luo Y; Yang Q; Zhang D; Yan W
    J Microbiol Biotechnol; 2021 Jan; 31(1):1-7. PubMed ID: 33323672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.